Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Doutor Nichires Holdings Co's revenue for the
three
months ended in Feb. 2026 was 円39,410 Mil.
Its revenue for the trailing twelve months (TTM) ended in Feb. 2026 was 円162,360 Mil.
Doutor Nichires Holdings Co's Revenue per Share for the
three
months ended in Feb. 2026 was 円93.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円2,992.54.
Warning Sign:
Doutor Nichires Holdings Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Doutor Nichires Holdings Co was 10.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -49.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -34.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -14.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Doutor Nichires Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 13.70% per year. The lowest was -49.20% per year. And the median was 3.80% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Doutor Nichires Holdings Co Revenue Related Terms
Doutor Nichires Holdings Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Restaurants subindustry, Doutor Nichires Holdings Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doutor Nichires Holdings Co Revenue vs Restaurants Industry
For the Restaurants industry and Consumer Cyclical sector, Doutor Nichires Holdings Co's Revenue distribution charts can be found below:
* The bar in red indicates where Doutor Nichires Holdings Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円162,360 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doutor Nichires Holdings Co (TSE:3087) has a Revenue of 円162,360 Mil as of Feb. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Doutor Nichires Holdings Co and its competitors.
Is Doutor Nichires Holdings Co's Revenue too high?
Doutor Nichires Holdings Co's current Revenue is 円162,360 Mil. Overall, Doutor Nichires Holdings Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Doutor Nichires Holdings Co's Revenue compare to MCD and SBUX?
Doutor Nichires Holdings Co's Revenue of 円162,360 Mil can be compared against companies in the Restaurants industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Restaurants company?
A good Revenue depends on the Restaurants industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Doutor Nichires Holdings Co and its competitors. Doutor Nichires Holdings Co's current Revenue is 円162,360 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doutor Nichires Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Doutor Nichires Holdings Co (TSE:3087) is currently considered Significantly Overvalued. The stock's GF Value™ is 円281.82, compared to a current price of 円3,410.00 — trading 1110% above its estimated fair value. The current Revenue is 円162,360 Mil. Doutor Nichires Holdings Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Doutor Nichires Holdings Co (TSE:3087), the current Revenue is 円162,360 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doutor Nichires Holdings Co (TSE:3087) Overvalued in 2026?
Based on GuruFocus' analysis, Doutor Nichires Holdings Co stock appears to be overvalued.
The current stock price of 円3,410.00 is trading 1110% above its estimated GF Value™ of 円281.82.
GuruFocus considers Doutor Nichires Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:3087:
Revenue: 円162,360 Mil
GF Value™: 円281.82 vs. price of 円3,410.00 (1110% above fair value)
No single metric tells the full story. See the TSE:3087 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doutor Nichires Holdings Co Ltd operate restaurants & coffee shops, manufactures bread & confectionery products, roasts coffee, imports & exports food, & manages franchise chains. The company's coffee shops & restaurants operate mainly in Japan under dozens of brand names that specialized in specific coffee and food types in the following categories: Italian coffee & sandwiches, Italian pasta, American food & coffee, Hawaiian coffee, & many others. Its business segments are: Restaurant System Group, which mainly operates restaurant chains with directly managed stores & the handling of ingredients. The Doutor Coffee Group operates coffee chains through its own stores & franchise system. Other refers to retail & wholesale business activities related to the food service industry.
58GF Score
Get the complete analysis for TSE:3087
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3087 has been successfully added to your 
